Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Parkinson's Disease

  Free Subscription


16.03.2026

2 Ann Neurol
1 BMC Neurol
1 Exp Brain Res
1 J Biol Chem
1 J Neural Transm (Vienna)
1 J Neurochem
1 J Neurol Neurosurg Psychiatry
5 Mov Disord
1 Nat Rev Neurol
1 Nervenarzt
2 Neurobiol Dis
1 PLoS Genet
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Neurol

  1. HENG YJ, Jayaraman A, Reynolds R, Foo JN, et al
    Predominance of Ferroptotic Cell Death Mechanisms in Substantia Nigra Neurodegeneration in Parkinson's Disease.
    Ann Neurol. 2026 Mar 10. doi: 10.1002/ana.78202.
    PubMed         Abstract available

  2. IBANEZ L, Pottier C, Beric A, Western D, et al
    Understanding Neurodegenerative Diseases From the -Omics Perspective: Lessons Learnt.
    Ann Neurol. 2026;99:566-587.
    PubMed         Abstract available


    BMC Neurol

  3. YUAN Y, Zhang Z, Shu Z, Wei Y, et al
    Prediction of depression development in Parkinson's disease patients: a radiomics-based machine learning study.
    BMC Neurol. 2026 Mar 12. doi: 10.1186/s12883-026-04779.
    PubMed        


    Exp Brain Res

  4. WANG X, Wang D, Zhang C, Zhang H, et al
    miR-214-3p exacerbates mitochondrial dysfunction in parkinson's disease: a multi-omics and mechanistic study.
    Exp Brain Res. 2026;244:60.
    PubMed         Abstract available


    J Biol Chem

  5. EALY A, Serapiglia AM, Panicker N
    Sterile innate immune mechanisms in neurodegenerative diseases.
    J Biol Chem. 2026;302:111039.
    PubMed         Abstract available


    J Neural Transm (Vienna)

  6. SMID A, Elting JWJ, van Laar T, Ten Kate JM, et al
    Perioperative quantification of MDS-UPDRS-III tremor measurements in patients with Parkinson's disease using accelerometry.
    J Neural Transm (Vienna). 2026 Mar 11. doi: 10.1007/s00702-026-03132.
    PubMed         Abstract available


    J Neurochem

  7. GOLDSTEIN DS, Sullivan P, Holmes C, Kema I, et al
    Emerging Role of Liquid Chromatography-Mass Spectrometry in the Clinical Laboratory Evaluation of Chronic Autonomic Failure.
    J Neurochem. 2026;170:e70405.
    PubMed         Abstract available


    J Neurol Neurosurg Psychiatry

  8. WANG J, Lam SP, Huang B, Liu Y, et al
    Familial alpha-synucleinopathy spectrum features in patients with psychiatric REM sleep behaviour disorder.
    J Neurol Neurosurg Psychiatry. 2023;94:893-903.
    PubMed         Abstract available


    Mov Disord

  9. POZZI R, De Sciscio M, Bosetti M, Cano-Crespo S, et al
    Glucocerebrosidase Target Engagement and Therapeutic Plasma and Cerebrospinal Fluid Levels After GT-02287 Administration in Healthy Volunteers.
    Mov Disord. 2026;41:522-527.
    PubMed         Abstract available

  10. CORRAL I, Martinez Castrillo JC, Bhatia KP, Garcia Ruiz PJ, et al
    A Pioneering 1915 Film on Movement Disorders in Spain: Parkinsonism, Huntington's Disease, and Paradoxical Kinesia.
    Mov Disord. 2026 Mar 7. doi: 10.1002/mds.70257.
    PubMed         Abstract available

  11. ISIK FI, Pickford R, Chua M, Lewis SJG, et al
    Elevation of Stearoyl-Coenzyme A Desaturase and Monounsaturated Fatty Acids in Parkinson's Disease Serum.
    Mov Disord. 2026 Mar 10. doi: 10.1002/mds.70264.
    PubMed         Abstract available

  12. STEP K, Hernandez CF, Khani M, Eltaraifee E, et al
    Genome-Wide Assessment Reveals Ancestral Differences in Homozygosity Patterns Potentially Linked to Parkinson's Disease Etiology.
    Mov Disord. 2026 Mar 11. doi: 10.1002/mds.70182.
    PubMed         Abstract available

  13. HAMMER LH, Cernera S, Oehrn CR, Yao J, et al
    Stimulation and Medication Effects on Subthalamic Nucleus Beta-Band Power in Parkinson's Disease: Implications for Adaptive Deep Brain Stimulation.
    Mov Disord. 2026 Mar 11. doi: 10.1002/mds.70261.
    PubMed         Abstract available


    Nat Rev Neurol

  14. GILAT M, Nonnekes J, Factor SA, Bloem BR, et al
    An updated definition of freezing of gait.
    Nat Rev Neurol. 2026 Jan 9. doi: 10.1038/s41582-025-01179.
    PubMed         Abstract available


    Nervenarzt

  15. BANG C, Heinzel S
    [Relationships between microbiome and neurodegeneration].
    Nervenarzt. 2023;94:885-891.
    PubMed         Abstract available


    Neurobiol Dis

  16. CHEN K, Ji Y, Zhang R, Lu L, et al
    Linking subjective cognitive decline to glymphatic dysfunction in Parkinson's disease.
    Neurobiol Dis. 2026;221:107344.
    PubMed         Abstract available

  17. LAU K, Porschen LT, Richter F, Gericke B, et al
    Microvascular blood-brain barrier alterations in isolated brain capillaries of mice over-expressing alpha-synuclein (Thy1-aSyn line 61).
    Neurobiol Dis. 2023;187:106298.
    PubMed         Abstract available


    PLoS Genet

  18. STEP K, Ndong Sima CAA, Grant S, Kim JJ, et al
    Polygenic risk scores and Parkinson's disease in South Africa advancing ancestry informed disease prediction.
    PLoS Genet. 2026;22:e1012064.
    PubMed         Abstract available


    PLoS One

  19. VASCONCELLOS LS, Taveira RS, de Melo LP, de Macedo Borges LRD, et al
    Effects of telerehabilitation-based physical therapy for individuals with Parkinson's disease: A systematic review protocol.
    PLoS One. 2026;21:e0342771.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum